Professor Raina MacIntyre

Professor Raina MacIntyre (MBBS Hons 1, FRACP, FAFPHM, M App Epid, PhD) is NHMRC Principal Research Fellow and Professor of Global Biosecurity. She heads the Biosecurity Program at the Kirby Institute, which conducts research in epidemiology, vaccinology, bioterrorism prevention, mathematical modelling, genetic epidemiology, public health and clinical trials in infectious diseases. Her research falls under 4 areas:  Personal protective equipment, Vaccinology, Epidemic response and emerging infectious diseases, and Bioterrorism prevention. She is a dual-specialist physician with training in epidemiology and modelling. Her research is underpinned by her clinical training, vaccine program experience and extensive field outbreak investigation experience.  She is currently on the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) and is the focal point for WHO GOARN in the ARM Network and UNSW GOARN member groups. She has developed an automated rapid epidemic intelligence platform, EPIWATCH, which uses AI to scan open source data for early epidemic signals. She leads a MRFF Frontiers Stage 1 grant in 2021 to further develop EPIWATCH into a global hub of epidemic detection, prevention and mitigation, with a suite of real-time decision support and risk analysis tools. The Epiwatch team includes data analysts, epidemiologists, machine learning experts and software engineers.

Raina has a 28-year track record in pandemics, epidemic infections, serious emerging infections, vaccines and control of respiratory viruses. She has worked as a clinician in hospitals, in health departments on outbreak control, and her PhD research was on screening, surveillance and contact tracing for TB and involved detailed tracking of the risk of infection in high risk contacts.  She worked for 15 years at the National Centre for Immunisation Research, and has conducted many vaccine clinical trials and has expertise in vaccinology and vaccine programs, especially vaccination of adults, at-risk and immunosuppressed populations.

She is a graduate of the Australian Field Epidemiology Training program, the MAE at ANU, and has extensive experience in shoe-leather epidemiology of infectious diseases outbreaks. Her in-depth understanding of the science of outbreak investigation draws from this experience combined with her academic training through a Masters and PhD in Epidemiology. She is best known for research in the detailed understanding of the transmission dynamics and prevention of infectious diseases, particularly respiratory pathogens such as influenza, tuberculosis, bioterrorism agents and vaccine-preventable infections. She has led the largest body of research internationally on face masks and respirators in health care workers. Her research has been influential in informing guidelines for health workers on PPE. She has extensive expertise in vaccination programs, with a particular interest in adult vaccination with a focus on the elderly and vaccines for bioterrorism. Specific vaccination interests include influenza, pneumococcal disease, HPV, smallpox, herpes zoster and SARS-CoV2. She has done a body of work on vaccine effectiveness of influenza vaccine against myocardial infarction. She led a NHMRC Centre for Research Excellence in immunisation for high risk populations, and is head of UNSW-VIRL, a vaccine research centre focused on adult and high-risk group vaccination. Her face mask research has focused on health care workers and hospitals. Her lab conducts research on aerosol dynamics and movement of respiratory droplets, in collaboration with aerospace and fluid mechanics engineers at UNSW. She has also done research on using risk-analysis methods for analysing the origins of emerging infectious diseases outbreaks such as MERS-CoV and is a leader in new approaches to biosecurity through cross-disciplinary response. She is involved in several research studies on COVID-19. She leads Biosecurity in Global Security PLuS and is interested in emerging threats to health security. She also designed and co-convenes a course, Bioterrorism and Health Intelligence, taken by students at UNSW and ASU.  She has led a pandemic simulation (Exercise Mataika, 2018 and Pacific Eclipse, 2019) in Australia and the US, which underpinned by modelling research and covers issues such as surveillance, diagnosis, health system capacity, mass quarantine, maritime transport and infected cruise ships, travel bans and the foundations of epidemic control. An online version of this, Unknown Biothreat Simulation, can be done as a self-paced exercise.

She leads a NHMRC Centre for Research Excellence, BREATHE, on mitigation of airborne threats to health.  She led a Centre for Research Excellence in Epidemic Response, ISER from 2016-2020. She has over 400 publications in peer-reviewed journals. Her passion for field epidemiology led her to co-found the ARM network for Australian outbreak response. She is currently on the Global Accreditation Board for TEPHINET, the network of global field epidemiology programs.

She also has an interest in the ethics of medicine, and specifically in dual-use research of concern, and has been on the World Organisation for Animal Health (OIE) committee for developing Guidelines For Responsible Conduct in Veterinary Research Identifying, Assessing and Managing Dual Use Research. She has research collaborations across the PLuS Alliance, with researchers from Arizona State University and Kings College London, and has an adjunct appointments at The College of Public Affairs and Community Solutions and the College of Health Solutions at ASU. She started a new cross-disciplinary journal, published by UNSW, Global Biosecurity, launched in February 2019.  See Google scholar profile

Interested in Raina's story? Read "First Responder". and Lunch with Raina MacIntyre

Zocalo Public Square (JP Getty Museum) panel "Is Civilisation on the Verge of Collapse" - Raina on pandemics in 2019

Ask the doctor - hygiene measures to prevent infection transmission

Research Highlights:

o    She won many career awards including the Sir Henry Wellcome Medal and Prize, from the Association of Military Surgeons of the United States in 2007 for her work on a risk-priority scoring system for category A bioterrorism agents; and the highest national award in infectious diseases, the Frank Fenner Award for Research in Infectious Diseases in 2003. She was a finalist in the 2021, 2020 and 2017 Eureka Prizes, won the the CAPHIA Research Team Prize in 2017, The Public Health Association of Australia National Immunisation Achievement Award in 2014, and also the Peter Baume Public Health Impact Prize in 2014. In 2012 she won the UNSW Medicine Dean's award for outstanding achievement, the highest award in the faculty of Medicine. She has previously held a NHMRC PhD scholarship and a NHMRC Career Development Award, and been a Harkness Fellow. She spent her Harkness fellowship studying the transmission of tuberculosis in prisons in the US, at Johns Hopkins University.

o    She has published the largest body of clinical trials of face masks in prevention of respiratory infections for health workers internationally, which has been a major new contribution to knowledge for pandemic planning. 

o    She is an expert in detection and mitigation of bioterrorism and biological warfare, with a deep understanding of epidemic control at the population level following an attack.

o    She initiated and led the creation, funding and training of the Network of Infectious Diseases Modellers of Australia through a NHMRC CBG in Population Health. This is a national network spanning three states and five Universities, which has had a prolific research output. She is interested in applying risk analysis methods to public health.

o    She leads a large program of vaccination clinical research, including studies in frail elderly vaccinology and in immunosuppressed populations such as bone marrow transplant recipients.

o    Led a NHMRC Centre for Research Excellence from 2012-2016, titled "Immunisation in under studied and special risk populations". www.creimmunisation.com.au 

Memberships & Professional Activities  

•  

• WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) 2021 (member)

  United States National Academies of Science, Engineering and Medicine Committee on public health interventions and countermeasures for advancing pandemic and seasonal influenza preparedness and response. Member, 2021.

• Member, NHMRC National COVID-19 Health and Research Advisory Committee 2020-2021
• Member, NSW Health COVID-19 Vaccine Advisory Group 2020-2021
• Member, Group of 8 advisory group on social distancing for COVID-19, 2020
• Member, Global Accreditation Board, TEPHINET 2017-current
• Member, World Organisation for Animal Health (OIE) Ad Hoc Committee on Guidelines for Managing Dual Use Research 2018.
• Fellow, Royal Society of NSW (elected 2016)
• Member, Australian Infection Prevention & Control Ebola Expert Advisory Group - 2014
• Member, WHO SAGE Committee on Varicella and Zoster Vaccine (2013-2014).
• Member, US National Academy of Sciences, Institute of Medicine, Committee on Respiratory Protection for Healthcare Workers Against Novel H1N1 Influenza A, 2009.
• Member of Council, Faculty of Public Health Medicine of Australia (2014-18)
• Member, Word Organization of Medical Editors (WAME) (2003-current)
• Member, Australian Society for Infectious Diseases (1998-2013)
• Member, Public Health Association of Australia - PHAA (current)
• One Health Special Interest Group committee, PHAA (current)
• Fellow, Royal Australasian College of Physicians
• Fellow, Australian Faculty of Public Health Medicine
• Member, Specialist Influenza Advisory Group to the Chief Medical Officer of Australia, 2007-2010
• Member, Pandemic Influenza Advisory Group to the Chief Medical Officer of Australia, 2007-2010
• Member, Association of Military Surgeons of the United States (2007-2009)
• Member, Infectious Diseases Subgroup of the Detention Health Advisory Group, Australia, 2007-.2008
• Member, National Health and Medical Research Council (NHMRC) Expert Advisory Group on Antimicrobial Resistance (EAGAR) (2005-2008).
• Member, Hepatitis B working party of the Ministerial Advisory Committee on AIDS, STDs and Hepatitis.
• Member, Working Parties for the Australian Technical Advisory Group on Immunisation: Influenza, Hepatitis A; Pneumococcal disease; Varicella zoster; Rotavirus   

Editorial Boards

Epidemiology and Infection

BMJ Open

Vaccine Council of 100

Global Biosecurity